| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fibrogen Inc (KYNB) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 22 sells. KYNB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 60.0K | $418.2K | - | |
| CFO | 26.0K | $181.2K | - | |
| Dir | 7.0K | $48.8K | - | |
| Dir | 7.0K | $48.8K | - | |
| Dir | 7.0K | $48.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 17, 2017 | Kurkijarvi Kalevi | Director | Sell | 2,000 | $33.45 | $66,900.00 | -5.9% | |
| Jul 10, 2017 | Yu K Peony | Chief Medical Officer | Sell | 5,000 | $32.98 | $164,900.00 | -2.3% | |
| Jul 7, 2017 | Neff Thomas B | Chief Executive Officer | Sale+OE | 38,636 | $33.38 | $1,289,547.46 | -0.4% | |
| Jul 6, 2017 | Cotroneo Pat | VP, Finance And CFO | Sale+OE | 4,000 | $34.00 | $136,000.00 | -2.4% | |
| Jun 22, 2017 | Cotroneo Pat | VP, Finance And CFO | Sale+OE | 3,000 | $32.00 | $96,000.00 | -1.8% | |
| Jun 22, 2017 | Neff Thomas B | Chief Executive Officer | Sale+OE | 38,636 | $31.52 | $1,217,645.32 | -0.4% | |
| Jun 19, 2017 | Cotroneo Pat | VP, Finance And CFO | Sale+OE | 5,500 | $30.00 | $165,000.00 | -3.3% | |
| Jun 16, 2017 | Neff Thomas B | Chief Executive Officer | Sale+OE | 38,636 | $29.40 | $1,135,734.48 | -0.6% | |
| Jun 15, 2017 | Kurkijarvi Kalevi | Director | Sell | 2,000 | $28.50 | $57,000.00 | -5.6% | |
| Jun 14, 2017 | Yu K Peony | Chief Medical Officer | Sell | 3,721 | $28.95 | $107,722.95 | -1.7% |